BRIEF published on 03/11/2026 at 18:35, 13 days ago Inoviem Scientific Advances Drug Development with Patient-Centric Approach Personalized Medicine Pharmaceutical Innovation Inoviem Scientific Patient-centric Drug Development Preclinical Programs
PRESS RELEASE published on 03/11/2026 at 18:30, 13 days ago ATON: UPDATE ON THE ACTIVITIES OF ITS SUBSIDIARY INOVIEM SCIENTIFIC Aton Group's subsidiary, Inoviem Scientific, transforms drug development by prioritizing patient samples & AI technology, accelerating preclinical programs with high-value translational data AI Technology Drug Development Inoviem Scientific Aton Group Patient Sample
BRIEF published on 03/11/2026 at 18:20, 13 days ago Inoviem Scientific: Advances in Pharmaceutical Development Personalized Medicine Pharmaceutical Development Translational Pharmacology Inoviem Scientific Integrated Platform
BRIEF published on 02/18/2026 at 18:35, 1 month 6 days ago Hadrien Lanvin Appointed Deputy CEO of Aton Group Biotechnology Strategic Growth Deputy CEO Hadrien Lanvin Aton Group
BRIEF published on 02/18/2026 at 18:35, 1 month 6 days ago Hadrien Lanvin appointed Deputy Managing Director of the Aton Group Biotechnology Life Sciences Appointment Hadrien Lanvin Aton Group
PRESS RELEASE published on 02/18/2026 at 18:30, 1 month 6 days ago ATON APPOINTS HADRIEN LANVIN AS DEPUTY CEO Aton Group appoints Hadrien Lanvin as Deputy CEO to drive value and visibility, strengthening leadership and strategic positioning. Focus on maximizing asset portfolio valuation and accelerating development Valuation Leadership Deputy CEO Hadrien Lanvin Aton Group
BRIEF published on 10/31/2025 at 18:05, 4 months 24 days ago 2025 Half-Year Results: Aton Confirms its Recovery Financial Recovery 2025 Results PIMS Technology Inoviem Scientific B Cell Design
BRIEF published on 10/08/2025 at 18:05, 5 months 16 days ago Strategic partnership between Inoviem Scientific and abc biopply in preclinical oncology Strategic Partnership 3D Models Therapeutic Innovation Preclinical Oncology Translational Pharmacology
BRIEF published on 09/29/2025 at 08:05, 5 months 25 days ago ATON Presents its New Strategy at the European MidCap Event 2025 Investors Governance Financial Strategy Aton European MidCap
BRIEF published on 09/17/2025 at 18:05, 6 months 7 days ago PIMS Technology secures €500,000 in funding from Bpifrance Funding Marketing Precision Medicine Bpifrance PIMS Technology
Published on 03/24/2026 at 18:55, 13 minutes ago Norse Gold Announces Closing of Private Placement Financing and Pending Reactivation on the TSX-V
Published on 03/24/2026 at 13:30, 5 hours 38 minutes ago GGL Resources Corp. Announces Closing of Earn-In Agreement with Nelson Resources Limited on Its Gold Point High-Grade Gold-Silver Project, Nevada
Published on 03/24/2026 at 13:30, 5 hours 38 minutes ago Innodata Announces Date of Annual Shareholder Meeting
Published on 03/24/2026 at 12:35, 6 hours 33 minutes ago Silver X Acquires the High-Grade Pampas Gold-Silver Project, Expanding its Precious Metal Asset Base in Peru
Published on 03/24/2026 at 12:33, 6 hours 35 minutes ago Mako Mining Completes Acquisition of Mt. Hamilton in Nevada
Published on 03/24/2026 at 18:39, 28 minutes ago EQS-Adhoc: FORTEC Elektronik Aktiengesellschaft: Adjustment of the earnings forecast for the financial year 2025/2026
Published on 03/24/2026 at 18:00, 1 hour 8 minutes ago Cham Swiss Properties places bond of CHF 100 million
Published on 03/24/2026 at 17:50, 1 hour 18 minutes ago Annual General Meeting of Bellevue Group AG – all proposals approved
Published on 03/24/2026 at 16:50, 2 hours 18 minutes ago LR Health & Beauty SE announces successful conclusion of the Written Procedure initiated on 6 March 2026 under the 2024/2028 Bonds and issuance of Super Senior Bonds
Published on 03/24/2026 at 17:46, 1 hour 22 minutes ago NRJ GROUP - Press release annual results 2025
Published on 03/24/2026 at 17:16, 1 hour 52 minutes ago Avaibility of the 2025 Universal Registration Document
Published on 03/24/2026 at 10:58, 8 hours 10 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of February 28, 2026
